Location: http://mtest.business-standard.com
Redirect IN else Aurobindo Pharma makes a decent start to FY18 | Business Standard

Aurobindo Pharma makes a decent start to FY18

Ujjval Jauhari | New Delhi Jun 29, 2017 03:23 AM IST

Aurobindo Pharma In a sector weighed down by bad news for some time, Aurobindo Pharma has done relatively better. In the past month and a half, the stock has outperformed its larger pharma peers on positive news flow. And, there could be more gains. The company made a good start to 2017-18, having got approvals for key generic launches in the US. This holds significance, with the pricing pressure on generics in the US, the world's largest health care market. The company has also seen the completion of a series of.....

TO READ THE FULL STORY, SUBSCRIBE NOW

Already a premium subscriber? LOGIN NOW.

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.

 

Advertisement
Ad
Ad
  
X

Share Box

Permalink